Development and validation of GC-MS method for the determination of methyl methanesulfonate and ethyl methanesulfonate in imatinib mesylate

Journal of Pharmaceutical and Biomedical Analysis

Volumn 46, Issue 4, 2008, Pages 780-783

  Ramakrishna, K ^a   Raman, N V V S S ^b   Rao, K M V Narayana ^b   Prasad, A V S S ^b   Reddy, K Subhaschander ^b  

^a GITAM UNIVERSITY   (India)

^b Hetero Drugs Limited   (India)

Author keywords

Development; Imatinib mesylate; Mesylate esters; Validation

Indexed keywords

IMATINIB; MESYLIC ACID DERIVATIVE;

ACCURACY; ARTICLE; ION PAIR CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; METHODOLOGY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

DRUG CONTAMINATION; ETHYL METHANESULFONATE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; METHYL METHANESULFONATE; PIPERAZINES; PYRIMIDINES;

EID: 39149085994     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.11.013     Document Type: Article

References (11)

1. IARC Monographs Program on the Evaluation of Carcinogenic Risks to Humans for Methyl Methanesulfonate, 71 (1999) 1059.
2. IARC Monographs Program on the Evaluation of Carcinogenic Risks to Humans for Ethyl Methanesulfonate, 7 (1974) 245.
3. Taylor G.E., Gosling M., and Pearce A. J. Chromatogr. A 1119 (2006) 231-237
4. The European Agency for the Evaluation of Medicinal Products, ICH Topic S1B, Note for Guidance on Carcinogenicity: Testing for Carcinogenicity of Pharmaceuticals, CPMP/ICH/299/95, 1998.
5. European Medicines Agency, Evaluation of Medicines for Human Use, Guideline on the Limits of Genotoxic Impurities, CPMP/SWP/5199/02, EMEA/CHMP/QWP/251344/2006, 2007.
6. The Merck Index, vol. 14, Merck & Co. Inc., Whitehouse Station, NJ, USA, 2006, p. 4905.
7. Ramjitt H.G., Singh M.M., and Coddington A.B. J. Mass Spectrom. 31 (1996) 867-872
8. Lee C.R., Guivarch F., Dau C.N.V., Tessier D., and Krstulovic A.M. Analyst 128 (2003) 857-863
9. Li W. J. Chromatogr. A 1046 (2004) 297-301
10. European Medicines Agency, ICH Topic Q 2 (R1), Note for Guidance on Validation of Analytical Procedures: Text and Methodology, CPMP/ICH/381/95, 1995.
11. The European Agency for the Evaluation of Medicinal Products, ICH topic Q 2 B, Note for Guidance on Validation of Analytical Procedures: Text and Methodology, CPMP/ICH/281/95, 1997.